Protara Therapeutics, Inc. · NASDAQ:TARA
Zummo Jacqueline sold 22,598 Protara Therapeutics, Inc. shares (Form 4)
Traded Apr 1, 2026 · Filed Apr 2, 2026
On Apr 1, 2026, Zummo Jacqueline (Chief R&D Officer) sold 22,598 Protara Therapeutics, Inc. shares at US$5.26 for US$119K, leaving 95,961 shares. Filed Apr 2, 2026 (Form 4).
- Sold
- 22,598 shares
- Price
- US$5.26
- Value
- US$119K
- Holding after
- 95,961 shares
- Trading plan
- No
- Role
- Chief R&D Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Apr 1, 2026 | Common Stock | Sale | 22,598 | US$5.26 | 95,961 | Direct |
Source
Related
- Protara Therapeutics, Inc.
- Zummo Jacqueline
- Protara Therapeutics, Inc. shareholders
- Form 4 · Zummo Jacqueline · Apr 9, 2026
- Schedule 13G/A · Janus Henderson Group PLC · Aug 13, 2026
- Schedule 13G/A · Millennium Management LLC · Jul 7, 2026
- Form 4 · Shefferman Jesse · Jul 1, 2026
- Form 4 · Conkling William · Jun 3, 2026
- Schedule 13G/A · Janus Henderson Group PLC · May 15, 2026